Evaluation of Self-care Activities and Quality of Life in Patients With Type 2 Diabetes Treated With Metformin Using the 2D Matrix Code of Outer Drug Packages as Patient Identifier: the DePRO Proof-of-Concept Observational Study

BACKGROUND: The use of digital technology to assess patients remotely can reduce clinical study costs. In the European Union, the 2D matrix code on prescription drug packaging serves as a unique identifier of a given package of medication, and thus, also of the patient receiving that medication. Sca...

Descripción completa

Detalles Bibliográficos
Autores principales: Mueller, Christian, Schauerte, Isabel, Martin, Stephan, Irrgang, Valeska
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175102/
https://www.ncbi.nlm.nih.gov/pubmed/35608887
http://dx.doi.org/10.2196/31832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175102/
https://www.ncbi.nlm.nih.gov/pubmed/35608887
http://dx.doi.org/10.2196/31832

Ejemplares similares